Share on StockTwits

Illumina (NASDAQ:ILMN) Director Roy A. Whitfield unloaded 4,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $143.71, for a total value of $574,840.00. Following the completion of the sale, the director now directly owns 9,196 shares of the company’s stock, valued at approximately $1,321,557. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

A number of analysts have recently weighed in on ILMN shares. Analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Separately, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Finally, analysts at Bank of America reiterated a “buy” rating on shares of Illumina in a research note on Wednesday, April 23rd. They now have a $195.00 price target on the stock. Eight research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $144.34.

Illumina (NASDAQ:ILMN) opened at 144.75 on Friday. Illumina has a one year low of $66.11 and a one year high of $183.30. The stock has a 50-day moving average of $142.1 and a 200-day moving average of $131.9. The company has a market cap of $18.586 billion and a price-to-earnings ratio of 101.79. Illumina also was the recipient of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 20,100,661 shares, a decrease of 7.0% from the April 15th total of 21,617,776 shares. Based on an average trading volume of 2,712,517 shares, the days-to-cover ratio is presently 7.4 days. Approximately 15.9% of the shares of the stock are sold short.

Illumina (NASDAQ:ILMN) last released its earnings data on Tuesday, April 22nd. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter last year, the company posted $0.46 earnings per share. Illumina’s revenue was up 27.2% compared to the same quarter last year. Analysts expect that Illumina will post $2.16 EPS for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.